Novavax Inc (NVAX)

234.00 +2.77  +1.20% NASDAQ Mar 1, 16:59 USD
View Full Chart
Price Chart
View All NVAX News

News

View All Events

Events

Date Type Description
03/01/2021 Earnings Novavax Inc Fourth Quarter Earnings Result for 2020
03/01/2021 16:30 EST Misc Novavax Inc Fourth Quarter Earnings Conference Call for 2020
11/09/2020 Earnings Novavax Inc Third Quarter Earnings Result for 2020
11/09/2020 16:30 EST Misc Novavax Inc Third Quarter Earnings Conference Call for 2020
08/10/2020 16:30 EDT Misc Novavax Inc Second Quarter Earnings Conference Call for 2020
08/10/2020 Earnings Novavax Inc Second Quarter Earnings Result for 2020
06/25/2020 08:30 EDT Misc Novavax Inc Annual General Meeting for 2019
05/11/2020 16:30 EDT Misc Novavax Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Novavax Inc First Quarter Earnings Result for 2020
03/11/2020 16:30 EDT Misc Novavax Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.novavax.com
  • Investor Relations URL: http://ir.novavax.com/phoenix.zhtml?c=71178&p=irol-irhome
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Mar. 01, 2021
  • Last Earnings Release: Mar. 01, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Top Fund Holders

Symbol Name Weighting
BBH VanEck Vectors Biotech ETF 5.12%
FRBRX Franklin Biotechnology Discovery R6 3.32%
XBI SPDR® S&P Biotech ETF 1.54%
FIJYX Fidelity Advisor® Biotechnology Z 1.26%
IBB iShares Nasdaq Biotechnology ETF 1.21%
IWN iShares Russell 2000 Value ETF 0.73%
SWSSX Schwab Small Cap Index 0.52%
IWM iShares Russell 2000 ETF 0.49%
VISVX Vanguard Small Cap Value Index Inv 0.45%
VBR Vanguard Small-Cap Value ETF 0.45%
NAESX Vanguard Small Cap Index Inv 0.29%
FSSNX Fidelity® Small Cap Index 0.26%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.